you are here: HomeNewsBusiness

India Inc facing cash flow problems, need a non-scheduled rate cut, says HDFC Bank’s Aditya Puri

As for investor concerns over the coronavirus impact on the bank’s financials, Puri said Q4 FY20 will not be flat and “you will be surprised with our numbers.”

March 23, 2020 / 03:23 PM IST

The HDFC Bank stock has seen a steep fall from Rs 1,069.80 levels at the close of March 13 close. The counter is trading at Rs 772 per share, down Rs 110.85 or 12.56 percent, on the NSE at 12:05 pm.

Despite the fall, Aditya Puri, Managing Director, HDFC Bank, allayed investor concerns saying the virus needs to be controlled first. “We are happy that the government announced a lockdown. Investors should concern ourselves with respect to the impact of coronavirus on the economy, not just financial markets. They have to understand that the world is not coming to an end. If companies will survive, the banking sector will survive,” Puri told CNBC-TV18.

He explained that bottom of the pyramid businesses and SMEs are not highly leveraged and that rural India was functioning well

As for investor concerns over the coronavirus impact on the bank’s financials, Puri said Q4 FY20 will not be flat and “you will be surprised with our numbers.”

Wading into the debate on whether the Monetary Policy Committee (MPC) should cut rates to stem the economic slowdown, he said there is need for a ‘non-scheduled rate cut’ as companies are facing a cash flow problem and not ‘going bust’. “The Reserve Bank has to give forbearance for the cash flow problem that the (corona)virus will create,” he said.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

Puri added that the Narendra Modi-led government ‘needs to spend like hell’ to boost health facilities and to create jobs.

To those fretting about the selloff in Indian equities, he said the recovery will be equally strong as even now ‘half the sales are happening via computers’.

Last week, the HDFC Bank ADR saw a sharp selloff. Puri attributed this to ‘programme selling’. He ruled out the probability of real investors being involved, saying he personally spoke with a number of big active investors and they ‘are not selling in any big way’.

To catch all live updates on the coronavirus pandemic, click here
Moneycontrol News
first published: Mar 23, 2020 12:28 pm

stay updated

Get Daily News on your Browser
ISO 27001 - BSI Assurance Mark